
Frist Cressey Ventures is a healthcare-focused venture capital firm that invests in early-stage technology and services businesses. Their strategy is to partner with innovative companies aiming to transform healthcare by improving care quality, patient outcomes, system efficiency, accessibility, and affordability, with a recent emphasis on AI-native business models.
94% of their portfolio is in Healthcare. Their most common stage is series-b (41% of deals). Average disclosed round size is $42.6M (across 17 rounds with reported amounts).
Portfolio
17
Fund Size
$1B
Top Stage
Series B
Last 12 Mo
3
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
17 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series A | $60M | Feb 2026 | |
| Series D | $97M | Sep 2025 | |
| Series B | $18.3M | May 2025 | |
| Series B | $16.5M | Jan 2025 | |
| Series C | $60M | Jan 2025 | |
| Series C | $95M | Jul 2024 | |
| Series A | $17M | Feb 2024 | |
| Series B | $60M | Aug 2023 | |
| Seed | $10.1M | Aug 2023 | |
| Series C | $75M | Jun 2023 | |
| Series B | $30M | Apr 2023 | |
| Unknown | $16M | Aug 2022 | |
| Series A | $15M | Mar 2022 | |
| Series B | $40M | Feb 2022 | |
| Series B | $50M | Jan 2022 | |
| Series A | $20M | Mar 2021 | |
| Series B | $45M | — |
Top Co-Investors
AlleyCorp5 shared
Transformation Capital4 shared
Foresite Capital3 shared
Kaiser Permanente Ventures3 shared
SpringRock Ventures3 shared
CVS Health3 shared
Providence Ventures2 shared
Andreessen Horowitz2 shared
Mass General Brigham Ventures2 shared
General Catalyst2 shared
Concord Health Partners2 shared
a16z Bio + Health2 shared
Memorial Hermann Health System2 shared
Flare Capital Partners2 shared
Casdin Capital1 shared
HC9 Ventures1 shared
Emerson Collective1 shared
Iconiq Capital1 shared
Northwell Health1 shared
PagsGroup1 shared
Last updated: 16 April 2026